| Bioactivity | AVLX-125 (UCCB01-125) is a PSD-95 and PDZ domain inhibitor with Kd value of 10 nM. AVLX-125 can be used in the study of inflammatory pain[1][2]. |
| CAS | 1786434-31-8 |
| Sequence | Val-Asp-Thr-Glu-Ile-Ile-Glu-Thr-Asp-Val Covalent bridge:Ile5-Ile6 |
| Shortening | VDTEIIETDV Covalent bridge:Ile5-Ile6 |
| Formula | C62H104N10O29 |
| Molar Mass | 1453.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Haugaard-Kedström L M, et al. Targeting PSD-95 as a novel approach in the treatment of stroke. Neuroprotective Therapy for Stroke and Ischemic Disease, 2017: 157-184. [2]. Andreasen JT, et al. UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801. Neuropharmacology. 2013 Apr;67:193-200. |